Gensynth Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 3.52 Cr
as on 24-10-2024
- Company Age 20 Year, 1 Day
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.25 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.80 Cr
as on 24-10-2024
- Revenue 35.25%
(FY 2023)
- Profit 26.57%
(FY 2023)
- Ebitda -59.19%
(FY 2023)
- Net Worth 1.54%
(FY 2023)
- Total Assets 59.99%
(FY 2023)
About Gensynth Laboratories
The Corporate was formerly known as Gensynth Fine Chemials Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.52 Cr.
The company currently has active open charges totaling ₹14.25 Cr. The company has closed loans amounting to ₹1.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhimavarapu Reddy, Ravi Gangapalli, Santhi Gangapalli, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230TG2004PTC044953
- Company No.
044953
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2004
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gensynth Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhimavarapu Reddy  | Managing Director | 23-Dec-2004 | Current |
| Ravi Gangapalli | Managing Director | 10-Oct-2020 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santhi Gangapalli | Additional Director | 25-Jun-2024 | Current |
| Madhi Varma | Additional Director | 10-Jun-2024 | Current |
| Prasanthi Emani | Director | 23-Dec-2004 | Current |
Financial Performance of Gensynth Laboratories.
Gensynth Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.25% increase. The company also saw a substantial improvement in profitability, with a 26.57% increase in profit. The company's net worth moved up by a moderate rise of 1.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gensynth Laboratories?
In 2023, Gensynth Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vanshika Laboratories Private LimitedActive 3 years 7 monthsRavi Gangapalli and Santhi Gangapalli are mutual person
- Surabhi Industries (India) Private LimitedActive 10 years 5 months
Ravi Gangapalli is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Oct 2020 | ₹1.85 M | Open |
Others Creation Date: 21 Oct 2020 | ₹1.83 M | Open |
Others Creation Date: 20 May 2020 | ₹1.37 Cr | Open |
How Many Employees Work at Gensynth Laboratories?
Gensynth Laboratories has a workforce of 83 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gensynth Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gensynth Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
